F18.988 Inhalant use, unspecified with other inhalant-induced disorder

Name of the Condition

• Common Name: Inhalant Use Disorder with Other Inhalant-Induced Disorder
• Medical Term: Inhalant Use, Unspecified with Other Inhalant-Induced Disorder

Summary

Inhalant use, unspecified with other inhalant-induced disorder, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by additional inhalant-related health issues. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related complications. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues, including other inhalant-induced disorders.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.
• Respiratory distress or other organ damage.
• Additional symptoms related to the specific inhalant-induced disorder.

Diagnosis

Diagnosis involves a thorough clinical evaluation, including a detailed history of inhalant use and associated symptoms. Healthcare providers assess for signs of inhalant misuse and other related disorders through physical exams, behavioral observations, and sometimes laboratory tests to rule out other conditions. Documentation of the specific inhalant-induced disorder is essential for accurate diagnosis.

Treatment Options

Treatment typically includes behavioral therapies, such as cognitive-behavioral therapy, to address inhalant use and related disorders. Supportive care may involve managing withdrawal symptoms, providing education on the risks of inhalant use, and coordinating with mental health professionals for co-occurring conditions. In some cases, medication may be used to address specific symptoms or underlying disorders.

Prognosis and Follow-Up

Prognosis depends on the severity of inhalant use and the presence of other disorders. Early intervention and consistent follow-up care improve outcomes. Long-term recovery often requires ongoing support, including therapy and monitoring for relapse. Regular check-ins with healthcare providers help track progress and adjust treatment as needed.

Complications

Complications may include respiratory failure, organ damage (e.g., liver or kidney), neurological impairment, or worsening of co-occurring mental health conditions. Chronic use can lead to irreversible harm, emphasizing the need for timely intervention.

Lifestyle & Prevention

Prevention focuses on reducing access to inhalants, especially for at-risk populations like adolescents. Education about the dangers of inhalant use, promoting healthy coping mechanisms, and fostering supportive environments can help prevent misuse. Avoiding environments where inhalants are readily available is also key.

When to Seek Professional Help

Seek professional help if there are signs of inhalant use, such as unexplained behavioral changes, physical symptoms, or concerns about misuse. Early intervention is critical to prevent complications and support recovery.

Tips for Medical Coders

Document the specific inhalant-induced disorder and its relationship to inhalant use clearly. Ensure the code F18.988 is used when the inhalant use is unspecified and accompanied by another inhalant-induced disorder. Verify that all relevant clinical details are captured to support accurate coding and billing.